About 9 results found for searched term "58-22-0" (0.062 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6105 | Testosterone | Androgen Receptor |
| (+)-Testosterone | ||
| Testosterone is an androgen, which binds the androgen receptor. | ||
| M6636 | CTA 056 | BTK |
| CTA 056 is a iTK inhibitor. | ||
| M17638 | Physaminimin D | Steroids |
| Physaminimin D | ||
| M17639 | Physaminimin C | Steroids |
| Physaminimin C | ||
| M21215 | CP-628006 | CFTR |
| CP-628006 is a CFTR small molecule enhancer that enhances CFTR function in human bronchial epithelial (hBE) cells and restores ATP-dependent gated channels in cystic fibrosis mutant G551D-CFTR. It can be used in cystic fibrosis (CF) related studies. | ||
| M24721 | Erenumab | CGRP Receptor |
| Erenumab is a first-in-class fully human monoclonal CGRP antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the research of episodic migraine. | ||
| M41216 | trans-Clopenthixol dihydrochloride | Parasite |
| trans-Clopenthixol ((E)-Clopenthixol) dihydrochloride is an antibiotic agent, without neuroleptic effect. | ||
| M43117 | Orziloben | Others |
| Orziloben is a medium chain fatty acid (MCFA) analogue. | ||
| M45287 | CK2/ERK8-IN-1 | Casein Kinase |
| CK2/ERK8-IN-1 is a dual inhibitor of casein kinase 2 (CK2) (Ki 0.25 µM) and ERK8 (MAPK15, ERK7), both with IC50s of 0.50 µM. In addition, CK2/ERK8-IN-1 binds to PIM1, HIPK2, and DYRK1A with Ki values of 8.65 µM, 15.25 µM, and 11.9 µM, respectively. 15.25 µM and 11.9 µM, respectively, and also has pro-apoptotic activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
